Richard Pzena Pzena Investment Management
Richard Pzena is the founder of Pzena Investment Management, a firm specializing in deep-value equities worldwide. The process systematically seeks companies trading at large discounts to normalized earnings power, often when sentiment is poor. Pzena’s research-driven value approach is widely followed by institutional allocators and value-focused individuals.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newell Brands
NWL
|
+$183M |
| 2 |
Lear
LEA
|
+$179M |
| 3 |
Shell
SHEL
|
+$175M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$166M |
| 5 |
SS&C Technologies
SSNC
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$513M |
| 2 |
Baker Hughes
BKR
|
+$322M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$174M |
| 4 |
Cenovus Energy
CVE
|
+$123M |
| 5 |
Textron
TXT
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.39% |
| 2 | Technology | 15.36% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Industrials | 11.52% |
| 5 | Energy | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Meta Platforms (Facebook)
META
$1.4T
| $646K | ﹤0.01% |
2,903
+1,565
| +117% | +$391K |
|
127
Regeneron Pharmaceuticals
REGN
$85.9B
| $645K | ﹤0.01% |
924
+20
| +2% | +$12.7K |
|
128
Halozyme
HALO
$12.3B
| $628K | ﹤0.01% |
+15,738
| New | +$561K |
|
129
Ituran Location and Control
ITRN
$1.01B
| $626K | ﹤0.01% |
27,215
+2,209
| +9% | +$51.4K |
|
130
Nokia
NOK
$57B
| $611K | ﹤0.01% |
111,936
+17,670
| +19% | +$97.9K |
|
131
Intel
INTC
$476B
| $527K | ﹤0.01% |
10,632
+2,704
| +34% | +$134K |
|
132
Qorvo
QRVO
$8.43B
| $527K | ﹤0.01% |
4,245
+2,657
| +167% | +$360K |
|
133
Biogen
BIIB
$32B
| $502K | ﹤0.01% |
+2,384
| New | +$518K |
|
134
United Therapeutics
UTHR
$22B
| $497K | ﹤0.01% |
2,768
+181
| +7% | +$34.5K |
|
135
Expeditors International
EXPD
$24.4B
| $490K | ﹤0.01% |
4,746
+3,050
| +180% | +$336K |
|
136
Williams-Sonoma
WSM
$28B
| $482K | ﹤0.01% |
+6,654
| New | +$504K |
|
137
Cencora
COR
$60.7B
| $476K | ﹤0.01% |
3,079
-1,554
| -34% | -$220K |
|
138
Lam Research
LRCX
$393B
| $473K | ﹤0.01% |
8,790
+2,120
| +32% | +$123K |
|
139
Exelixis
EXEL
$13.4B
| $469K | ﹤0.01% |
+20,669
| New | +$404K |
|
140
IPG Photonics
IPGP
$3.12B
| $460K | ﹤0.01% |
+4,192
| New | +$576K |
|
141
Playtika
PLTK
$904M
| $441K | ﹤0.01% |
+22,824
| New | +$406K |
|
142
Barclays
BCS
$90.2B
| $437K | ﹤0.01% |
55,321
| – | – |
|
143
Skyworks Solutions
SWKS
$10.1B
| $428K | ﹤0.01% |
+3,209
| New | +$450K |
|
144
Merck
MRK
$376B
| $418K | ﹤0.01% |
5,092
-1,793
| -26% | -$141K |
|
145
Yeti Holdings
YETI
$3.19B
| $404K | ﹤0.01% |
+6,729
| New | +$434K |
|
146
Dell
DELL
$286B
| $382K | ﹤0.01% |
7,618
| – | – |
|
147
Humana
HUM
$45.5B
| $367K | ﹤0.01% |
844
| – | – |
|
148
Maximus
MMS
$3.05B
| $349K | ﹤0.01% |
4,657
+24
| +0.5% | +$1.84K |
|
149
D.R. Horton
DHI
$41.5B
| $297K | ﹤0.01% |
+3,981
| New | +$345K |
|
150
C.H. Robinson
CHRW
$16.5B
| $277K | ﹤0.01% |
2,572
-1,816
| -41% | -$184K |
|
Similar funds
Richard Pzena's Q1 2022 Portfolio in Review
As of Q1 2022, Richard Pzena held 192 positions worth $26.5B, down 0.29% from $26.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Richard Pzena's Q1 2022 filing shows 18 new, 78 increased, 54 reduced and 15 closed positions. Its largest new stake was Shell: 3,298,328 shares worth $181M. The largest sale was Halliburton, an estimated $513M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
- Richard Pzena's largest Q1 2022 buy was Shell: 3,298,328 shares worth $181M.
- Richard Pzena added most to Newell Brands in Q1 2022, an estimated $183M increase.
- Richard Pzena's biggest Q1 2022 reduction was Halliburton, cutting an estimated $513M.
- Richard Pzena fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $174M.
- Richard Pzena's ten largest holdings make up 36% of its $26.5B portfolio in Q1 2022.
- Richard Pzena opened 18 new positions and closed 15 in Q1 2022.
- Richard Pzena's portfolio value fell 0.29% quarter-over-quarter to $26.5B.
Based on Pzena Investment Management's 13F filing for Q1 2022, filed 6 May 2022.